These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6271686)

  • 21. Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice.
    Klein RJ; DeStefano E; Friedman-Kien AE; Brady E
    Antimicrob Agents Chemother; 1981 May; 19(5):937-9. PubMed ID: 6271054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in the number of sites of latency of herpes simplex virus in trigeminal ganglia of inbred mice.
    Abghari SZ; Stulting RD
    Curr Eye Res; 1988 Dec; 7(12):1155-62. PubMed ID: 2852578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novobiocin and coumermycin A1 inhibit viral replication and the reactivation of herpes simplex virus type 1 from the trigeminal ganglia of latently infected mice.
    Spivack JG; O'Boyle DR; Fraser NW
    J Virol; 1987 Oct; 61(10):3288-91. PubMed ID: 3041048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting recovery of latent herpes simplex virus from human trigeminal ganglia.
    Lewis ME; Warren KG; Jeffrey VM; Shnitka TK
    Can J Microbiol; 1982 Jan; 28(1):123-9. PubMed ID: 6279261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spontaneous ocular shedding of HSV-1 in latently infected rabbits.
    Berman EJ; Hill JM
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):587-90. PubMed ID: 2984140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of prolonged cultivation in the presence of acyclovir on recovery of latent herpes simplex virus from human trigeminal ganglia.
    Lewis ME; Warren KG; Jeffrey VM; Tyrrell DL
    Antimicrob Agents Chemother; 1983 Mar; 23(3):487-9. PubMed ID: 6303216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of immunization and immunosuppression on induced ocular shedding and recovery of herpes simplex virus in infected rabbits.
    Green MT; Dunkel EC; Pavan-Langston D
    Exp Eye Res; 1987 Sep; 45(3):375-83. PubMed ID: 2822456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of HSV-1 DNA species from trigeminal ganglia of rabbits during acute and latent infections.
    Green MT; Qavi HB; SeGall GK
    Curr Eye Res; 1987 Jan; 6(1):85-9. PubMed ID: 3030658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes simplex virus: recurrent and nonrecurrent strains.
    Centifanto-Fitzgerald Y; Caldwell DR; Yates F
    Proc Soc Exp Biol Med; 1987 Sep; 185(4):484-92. PubMed ID: 3039520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B radiation.
    Laycock KA; Lee SF; Brady RH; Pepose JS
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2741-6. PubMed ID: 1654309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of herpes simplex virus type 1 latency-associated transcripts in the trigeminal ganglia of mice during acute infection and reactivation of latent infection.
    Spivack JG; Fraser NW
    J Virol; 1988 May; 62(5):1479-85. PubMed ID: 2833602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of latent ganglionic infection with herpes simplex virus via maxillary gingiva and viral re-activation in vivo after trauma.
    Shimizu F; Monma Y; Sekizawa T; Kamiyama K
    J Dent Res; 1989 Mar; 68(3):472-5. PubMed ID: 2537858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
    Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition by indomethacin of in vitro reactivation of latent herpes simplex virus type 1 in murine trigeminal ganglia.
    Kurane I; Tsuchiya Y; Sekizawa T; Kumagai K
    J Gen Virol; 1984 Oct; 65 ( Pt 10)():1665-74. PubMed ID: 6092519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reliable in vivo model for latent herpes simplex virus reactivation with peripheral virus shedding.
    Nesburn AB; Green MT; Radnoti M; Walker B
    Infect Immun; 1977 Mar; 15(3):772-5. PubMed ID: 192675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of ibuprofen on the in vitro and in vivo reactivation of latent HSV-1.
    Cherrick HM; Li KK; Li SL; Park NH
    Oral Surg Oral Med Oral Pathol; 1992 Mar; 73(3):321-7. PubMed ID: 1312234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model.
    Trousdale MD; Steiner I; Spivack JG; Deshmane SL; Brown SM; MacLean AR; Subak-Sharpe JH; Fraser NW
    J Virol; 1991 Dec; 65(12):6989-93. PubMed ID: 1658388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice.
    Liu WG; Chen ZJ; Song JZ; Ma ZX
    Antimicrob Agents Chemother; 1986 Feb; 29(2):278-80. PubMed ID: 2424367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular herpes simplex and the establishment of latent infection.
    Tullo AB; Easty DL; Hill TJ; Blyth WA
    Trans Ophthalmol Soc U K (1962); 1982 Apr; 102 (Pt 1)():15-8. PubMed ID: 6301114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of immune serum on the establishment of herpes simplex virus infection in trigeminal ganglia of hairless mice.
    Klein RJ
    J Gen Virol; 1980 Aug; 49(2):401-5. PubMed ID: 6255074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.